Chris Newmarker
Executive Editor, Life Sciences at MassDevice
Executive Editor, Life Sciences at Medical Design & Outsourcing
Executive Editor, Life Sciences at Pharmaceutical Processing World
Executive Editor, Life Sciences at Drug Discovery & Development
Executive Editor, Life Sciences at Medical Tubing + Extrusion
A journalist for over 20 years, I am executive editor of Life Sciences at WTWH Media. Media outlets include MassDevice, Medical Design & Outsourcing and more.
Articles
-
3 weeks ago |
massdevice.com | Chris Newmarker
Johnson & Johnson must now pay $442 million in damages in an antitrust case over cardiac mapping catheter reprocessing. Federal law enables the tripling of antitrust damages, and that’s what U.S. District Judge James V. Selna did in his judgment yesterday. A federal jury in Selna’s court in Central California hit J&J’s Biosense Webster business with a $147 million verdict last month.
-
3 weeks ago |
medicaldesignandoutsourcing.com | Chris Newmarker
Major medtech accelerator MedTech Innovator has selected 65 startups out of an applicant pool of 1,500 to compete in its prestigious four-month program. On top of a chance to compete for $800,000 in non-dilutive funding, the 65 companies participate in a four-month program where they can de-risk innovations and accelerate their path to the U.S. market, as well as gain access to some of the top companies in the medical device industry.
-
3 weeks ago |
massdevice.com | Chris Newmarker
HistoSonics announced today that it has completed patient enrollment of its pivotal #HOPE4KIDNEY trial to evaluate its Edison histotripsy system in treating kidney tumors. The Edison system has already received FDA de novo clearance for treating liver tumors; HistoSonics says major academic centers and hospitals across the U.S are adopting it. The Edison system uses focused ultrasound energy.
-
3 weeks ago |
therobotreport.com | Chris Newmarker
HistoSonics announced last week that its Edison histotripsy system for noninvasively destroying liver tumors has secured limited U.K. market access. According to the Plymouth, Minn.–based company, the Medicines and Healthcare Products Regulatory Agency in Great Britain granted controlled early limited market access under an Unmet Clinical Need Authorisation available through the U.K.’s Innovative Devices Access Pathway (IDAP) program.
-
3 weeks ago |
massdevice.com | Chris Newmarker
Larry Jones, the former CIO of Johnson & Johnson MedTech (NYSE: JNJ) Johnson & Johnson Open 154.041 Day High 155.493 52 Week High 170.27 52 Week Low 141.57 , has joined Microsoft as its global Healthcare & Life Sciences (HLS) industry leader. Jones will report to Shelley Bransten, Microsoft’s corporate VP of Global Industry Solutions, who made the announcement on LinkedIn today.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 2K
- Tweets
- 6K
- DMs Open
- No
According to Outset Medical, Inc., the FDA’s warning letter does not request the restriction of Tablo’s manufacturing, production or shipment in the U.S. It also does not request the withdrawal of the system from the U.S. market. S…https://t.co/MLauvwVNZR https://t.co/NJdmv6kHiU
#Medtech #meddevice industry #mergersandacquisitions continue. This time, Coloplast is buying. https://t.co/XgjNYEgaqZ
This move marks the second software-related buy in the past year for ResMed. #medtech #mergersandacquisitions #digitalhealth #sleepapnea #cpap https://t.co/p1UljWrAAL